Published ahead of print on November 24, 2004, doi:10.1164/rccm.200409-1275OC
Am. J. Respir. Crit. Care Med., Volume 171, Number 7, April 2005, 734-742
A more recent version of this article appeared on April 1, 2005
Submitted on September 28, 2004
Accepted on November 18, 2004
An Animal Model of Autoimmune Emphysema
Laimute Taraseviciene-Stewart1, Robertas Scerbavicius1, Kang-Hyeon Choe1, Melissa Moore1, Andrew Sullivan1, Mark R Nicolls2, Andrew P Fontenot3, Rubin M Tuder4, and Norbert F Voelkel1*
1 Department of Medicine, Division of Pulmonary Sciences and Critical Care, University of Colorado Health Sciences Center, Denver, CO, USA,
2 Department of Medicine, Division of Pulmonary Sciences and Critical Care, University of Colorado Health Sciences Center, Denver, CO, USA; Department of Immunology, University of Colorado Health Sciences Center, Denver, CO, USA,
3 Department of Immunology, University of Colorado Health Sciences Center, Denver, CO, USA,
4 Department of Pathology, Division of Cardiopulmonary Pathology, Johns Hopkins University, Baltimore, MD, USA
* To whom correspondence should be addressed. E-mail: Norbert.Voelkel{at}UCHSC.edu.
Although cigarette smoking is implicated in the pathogenesis of emphysema, the precise mechanisms of chronic progressive alveolar septal destruction are not well understood. Here we show in a novel animal model that immune competent, but not athymic nude rats injected intraperitonealy with xenogeneic endothelial cells produce antibodies against endothelial cells and develop emphysema. Immunization with endothelial cells also leads to alveolar septal cell apoptosis and activation of matrix metalloproteases MMP-9 and MMP-2. Anti-endothelial cell antibodies cause endothelial cell apoptosis in vitro and emphysema in passively immunized mice. Moreover, immunization also causes accumulation of CD4+ T-cells in the lung. Adoptive transfer of pathogenic, spleen-derived CD4+ cells into naive immune-competent animal also results in emphysema. In this study we show for the first time that humoral- and CD4+ cell-dependent mechanisms are sufficient to trigger the development of emphysema, suggesting that alveolar septal cell destruction might result from immune mechanisms.
Key words: emphysema, endothelial cells, antibodies, T cells, cellular immune response
This article has been cited by other articles:

|
 |

|
 |
 
G. T. Motz, B. L. Eppert, G. Sun, S. C. Wesselkamper, M. J. Linke, R. Deka, and M. T. Borchers
Persistence of Lung CD8 T Cell Oligoclonal Expansions upon Smoking Cessation in a Mouse Model of Cigarette Smoke-Induced Emphysema
J. Immunol.,
December 1, 2008;
181(11):
8036 - 8043.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Wright, M. Cosio, and A. Churg
Animal models of chronic obstructive pulmonary disease
Am J Physiol Lung Cell Mol Physiol,
July 1, 2008;
295(1):
L1 - L15.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. F. Chung and I. M. Adcock
Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction
Eur. Respir. J.,
June 1, 2008;
31(6):
1334 - 1356.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Kim, T. J. Rogers, and G. J. Criner
New Concepts in the Pathobiology of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
May 1, 2008;
5(4):
478 - 485.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Barcelo, J. Pons, J. M. Ferrer, J. Sauleda, A. Fuster, and A. G. N. Agusti
Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking
Eur. Respir. J.,
March 1, 2008;
31(3):
555 - 562.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Mori, T. Nose, K. Ishitani, S. Kasagi, S. Souma, T. Akiyoshi, Y. Kodama, T. Mori, M. Kondo, S. Sasaki, et al.
Phosphodiesterase 4 inhibitor GPD-1116 markedly attenuates the development of cigarette smoke-induced emphysema in senescence-accelerated mice P1 strain
Am J Physiol Lung Cell Mol Physiol,
February 1, 2008;
294(2):
L196 - L204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Feghali-Bostwick, A. S. Gadgil, L. E. Otterbein, J. M. Pilewski, M. W. Stoner, E. Csizmadia, Y. Zhang, F. C. Sciurba, and S. R. Duncan
Autoantibodies in Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
January 15, 2008;
177(2):
156 - 163.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Fabbri, F. Luppi, B. Beghe, and K. F. Rabe
Complex chronic comorbidities of COPD
Eur. Respir. J.,
January 1, 2008;
31(1):
204 - 212.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. W. Lam, D. W. Holdsworth, L. Y. Du, M. Drangova, D. G. McCormack, and G. E. Santyr
Micro-CT imaging of rat lung ventilation using continuous image acquisition during xenon gas contrast enhancement
J Appl Physiol,
November 1, 2007;
103(5):
1848 - 1856.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Curtis, C. M. Freeman, and J. C. Hogg
The Immunopathogenesis of Chronic Obstructive Pulmonary Disease: Insights from Recent Research
Proceedings of the ATS,
October 1, 2007;
4(7):
512 - 521.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Wright and A. Churg
Current Concepts in Mechanisms of Emphysema
Toxicol Pathol,
January 1, 2007;
35(1):
111 - 115.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Tuder, T. Yoshida, I. Fijalkowka, S. Biswal, and I. Petrache
Role of Lung Maintenance Program in the Heterogeneity of Lung Destruction in Emphysema
Proceedings of the ATS,
November 1, 2006;
3(8):
673 - 679.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Taraseviciene-Stewart, I. S. Douglas, P. S. Nana-Sinkam, J. D. Lee, R. M. Tuder, M. R. Nicolls, and N. F. Voelkel
Is Alveolar Destruction and Emphysema in Chronic Obstructive Pulmonary Disease an Immune Disease?
Proceedings of the ATS,
November 1, 2006;
3(8):
687 - 690.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Bracke, A. I. D'hulst, T. Maes, K. B. Moerloose, I. K. Demedts, S. Lebecque, G. F. Joos, and G. G. Brusselle
Cigarette Smoke-Induced Pulmonary Inflammation and Emphysema Are Attenuated in CCR6-Deficient Mice
J. Immunol.,
October 1, 2006;
177(7):
4350 - 4359.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Taraseviciene-Stewart, R. Scerbavicius, K.-H. Choe, C. Cool, K. Wood, R. M. Tuder, N. Burns, M. Kasper, and N. F. Voelkel
Simvastatin causes endothelial cell apoptosis and attenuates severe pulmonary hypertension
Am J Physiol Lung Cell Mol Physiol,
October 1, 2006;
291(4):
L668 - L676.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. O. C. Cookson
State of the Art. Genetics and Genomics of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
August 1, 2006;
3(6):
473 - 475.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Agusti
Thomas A. Neff Lecture. Chronic Obstructive Pulmonary Disease: A Systemic Disease
Proceedings of the ATS,
August 1, 2006;
3(6):
478 - 481.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Gadgil, X. Zhu, F. C. Sciurba, and S. R. Duncan
Altered T-Cell Phenotypes in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
August 1, 2006;
3(6):
487 - 488.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Tuder, T. Yoshida, W. Arap, R. Pasqualini, and I. Petrache
State of the Art. Cellular and Molecular Mechanisms of Alveolar Destruction in Emphysema: An Evolutionary Perspective
Proceedings of the ATS,
August 1, 2006;
3(6):
503 - 510.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. MacNee
Conference Summary
Proceedings of the ATS,
August 1, 2006;
3(6):
539 - 542.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Taraseviciene-Stewart, N. Burns, D. Kraskauskas, M. R. Nicolls, R. M. Tuder, and N. F. Voelkel
Mechanisms of Autoimmune Emphysema
Proceedings of the ATS,
August 1, 2006;
3(6):
486a - 487.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Fabbri, F. Luppi, B. Beghe, and K. F. Rabe
Update in chronic obstructive pulmonary disease 2005.
Am. J. Respir. Crit. Care Med.,
May 15, 2006;
173(10):
1056 - 1065.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J C Hogg
Why does airway inflammation persist after the smoking stops?
Thorax,
February 1, 2006;
61(2):
96 - 97.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. F. Voelkel, R. W. Vandivier, and R. M. Tuder
Vascular endothelial growth factor in the lung
Am J Physiol Lung Cell Mol Physiol,
February 1, 2006;
290(2):
L209 - L221.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. T. G. Elkington, R. K. Nuttall, J. J. Boyle, C. M. O'Kane, D. E. Horncastle, D. R. Edwards, and J. S. Friedland
Mycobacterium tuberculosis, but Not Vaccine BCG, Specifically Upregulates Matrix Metalloproteinase-1
Am. J. Respir. Crit. Care Med.,
December 15, 2005;
172(12):
1596 - 1604.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-H. Lee, D.-S. Lee, E.-K. Kim, K.-H. Choe, Y.-M. Oh, T.-S. Shim, S.-E. Kim, Y.-S. Lee, and S.-D. Lee
Simvastatin Inhibits Cigarette Smoking-induced Emphysema and Pulmonary Hypertension in Rat Lungs
Am. J. Respir. Crit. Care Med.,
October 15, 2005;
172(8):
987 - 993.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Sullivan, P. L. Simonian, M. T. Falta, J. D. Mitchell, G. P. Cosgrove, K. K. Brown, B. L. Kotzin, N. F. Voelkel, and A. P. Fontenot
Oligoclonal CD4+ T Cells in the Lungs of Patients with Severe Emphysema
Am. J. Respir. Crit. Care Med.,
September 1, 2005;
172(5):
590 - 596.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 American Thoracic Society
|
|
|